by October Gallery
TORONTO (Reuters) – Canada opposes any U.S. plans to buy Canadian prescription drugs that might threaten the country’s drug supply or raise costs for its own citizens, officials have told…
(Reuters) – Drugmaker Indivior Plc said on Thursday its former parent Reckitt Benckiser’s $1.4 billion settlement with authorities in the United States was separate to its ongoing legal proceedings. Reckitt…
(Reuters) – Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company…
(Reuters) – Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company…
(Reuters) – CannTrust Holdings Inc’s shares plunged about 23% to a more than one-and-half-year low on Monday, after Health Canada found the weed producer grew cannabis in unlicensed rooms, and…
(Reuters) – Novartis AG (NOVN.S) said on Tuesday it would make its generic pre-filled epinephrine shots immediately available in local pharmacies across the United States, as a shortage of Mylan…
FILE PHOTO: EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg/File Photo (Reuters)…
(Reuters) – The U.S. Food and Drug Administration said on Monday three deaths had been reported related to Edwards Lifesciences Corp’s recall of some of its heart devices. The agency…
(Reuters) – Japan’s Daiichi Sankyo Co said on Friday the U.S. Food and Drug Administration has declined to approve its drug quizartinib as a treatment for adults with a type…
(Reuters) – Pfizer Inc on Monday said it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon…